AlloVir, Inc. (ALVR)
NASDAQ: ALVR · Real-Time Price · USD
0.570
+0.011 (1.93%)
At close: Nov 20, 2024, 4:00 PM
0.569
-0.001 (-0.19%)
After-hours: Nov 20, 2024, 4:04 PM EST
AlloVir Market Cap
AlloVir has a market cap or net worth of $65.16 million as of November 21, 2024. Its market cap has decreased by -63.65% in one year.
Market Cap
65.16M
Enterprise Value
-56.69M
1-Year Change
-63.65%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since July 30, 2020, AlloVir's market cap has decreased from $1.43B to $65.16M, a decrease of -95.45%. That is a compound annual growth rate of -51.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 63.92M | -15.02% |
| Dec 29, 2023 | 75.22M | -83.78% |
| Dec 30, 2022 | 463.83M | -42.20% |
| Dec 31, 2021 | 802.46M | -66.14% |
| Dec 31, 2020 | 2.37B | 65.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InspireMD | 67.56M |
| CytomX Therapeutics | 67.55M |
| Boundless Bio | 66.67M |
| Cryo-Cell International | 66.27M |
| Cue Biopharma | 66.23M |
| Pheton Holdings | 66.12M |
| Metagenomi | 65.49M |
| bluebird bio | 64.75M |